Strides Pharma Reports Net Profit Of ₹10.44 Cr In Q4FY24
Total expenses in the fourth quarter were higher at Rs 984.21 crore as compared to Rs 972.26 crore.
Source: freepressjournal.in
Stay updated with breaking news from Pharma Founder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Total expenses in the fourth quarter were higher at Rs 984.21 crore as compared to Rs 972.26 crore.
EQS-News: Sunshine Biopharma Inc. What Does Sunshine Biopharma’s Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market? 07.11.2022 / 15:28 CET/CEST The issuer is solely responsible for the content of this announcement. The generic drug market has been growing since 1984 when ...